“BD Vacutainer Eclipse Needles: Blood Leakage Risk from Missing Bevel.” GovInfoNow, updated August 20, 2026. https://govinfonow.com/recall/68900-bd-vacutainer-eclipse-needles-blood-leakage-risk-from-missing-bevel. Based on FDA recall #Z-0252-2020 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0252-2020%22&limit=1).
The FDA announced on March 7, 2019, that Becton Dickinson & Company is recalling BD Vacutainer Eclipse Blood Collection Needles due to blood leakage hazards. The agency issued recall number Z-0252-2020 for the affected devices.
BD PAS received customer complaints indicating the absence of the bevel on the non-patient needle end of the product, causing blood leakage.
Context
GovInfoNow's records show Becton Dickinson & Company has 52 other recalls on record since May 31, 2017. Recent brand recalls include a spinal tray recall for quality issues identified during an FDA inspection on April 27, 2026, and a recall of 10mL non-sterile Luer-Lok syringes due to wrong syringe type on January 27, 2026. Other recent recalls of similar products include Becton Dickinson Swan-Ganz Jr Catheter Recall: Leaking Hub Risk (April 8, 2026), Becton Dickinson Swan-Ganz Catheter Recall: Leak Risk from Hub (April 8, 2026), and Becton Dickinson Swan-Ganz Catheter Recall: Risk of infection from leaking hub (April 8, 2026).
How to tell if you have this one
Check the product label for the model number 22Gx1.25 and lot numbers: 8207894, 9025826, 8354527, or 9010765. The product is sold by Becton Dickinson.
Brand
Becton Dickinson
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Needle Lot Number
Look for the lot number on the needle packaging or label to determine if it's affected.
Where it went and when
Where it was distributed
Distributed in 13 states, and outside the U.S.
Listed by the agency
Not listed
FDA distribution: “Distributed to accounts in AR, CT, FL, IL, IN, MI, MO, MS, NY, OH, TN, TX, and VA. Foreign distribution to Canada, Brazil, India, Mexico, Singapore, and Taiwan.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Arkansas, Connecticut, Florida, Illinois, Indiana, Michigan, Mississippi, Missouri, New York, Ohio, Tennessee, Texas, Virginia.
Recall timeline
FDA terminated this recall 2.9 years after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-0252-2020 (March 7, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0252-2020 to see it in context.
Plain-language summary written by qwen3:4b on August 20, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.